Vineet LaboratoriesNSE:VINEETLAB +0.18%38 Interest Coverage is 1.70 as of Dec. 2025, which is 100% below its 10-year median of 5,003.75. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 38/100 and a GF Value™ of ₹15.48 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,234 Chemicals companies, Vineet Laboratories ranks worse than 81037.2% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Vineet Laboratories's
Operating Income
for the
three
months ended in Dec. 2025 was ₹18.7 Mil. Vineet Laboratories's Interest Expense for the
three
months ended in Dec. 2025 was ₹-10.9 Mil.
Vineet Laboratories's interest coverage for the quarter that ended in Dec. 2025 was 1.70.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Vineet Laboratories's Interest Coverage or its related term are showing as below:
NSE:VINEETLAB's Interest Coverage is not ranked *
in the Chemicals industry.
Industry Median: 10.18 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Vineet Laboratories Interest Coverage Related Terms
Vineet Laboratories Interest Coverage Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:VINEETLAB vs DOW: Interest Coverage Comparison
For the Chemicals subindustry, Vineet Laboratories's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories Interest Coverage vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories (NSE:VINEETLAB) has a Interest Coverage of 1.70 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vineet Laboratories and its competitors. This is 100% below median its historical median of 5,003.75. According to the industry distribution chart, Vineet Laboratories ranks #999999 out of 1234 companies in the Chemicals industry.
Is Vineet Laboratories' Interest Coverage too high?
Vineet Laboratories' current Interest Coverage of 1.70 is 100% below median its 10-year median of 5,003.75. The Chemicals industry median Interest Coverage is 10.18. Vineet Laboratories' value of 1.70 is 83.3% below this industry median. Based on the distribution chart, Vineet Laboratories ranks #999999 out of 1234 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Interest Coverage compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #999999 out of 1234 companies for Interest Coverage. This places Vineet Laboratories in the lower half of its industry. The industry median Interest Coverage is 10.18. Vineet Laboratories' value of 1.70 is 83.3% below this benchmark. While the company's 10-year median is 5,003.75 vs. the industry median of 10.18, Vineet Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Chemicals company?
The median Interest Coverage among Chemicals companies is 10.18, based on 1,234 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current Interest Coverage of 1.70 is 83.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median Interest Coverage is 10.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current Interest Coverage is 1.70, which is 100% below median its own 10-year median of 5,003.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.48, compared to a current price of ₹34.00 — trading 119.6% above its estimated fair value. The current Interest Coverage is 1.70, which is 100% below median its 10-year median of 5,003.75 and 83.3% below the Chemicals industry median of 10.18. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Interest Coverage is 1.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹34.00 is trading 119.6% above its estimated GF Value™ of ₹15.48.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
Interest Coverage: 1.70 (100% below median its 10-year median of 5,003.75)
GF Value™: ₹15.48 vs. price of ₹34.00 (119.6% above fair value)
Industry Position: 83.3% below the Chemicals median (#999999 of 1234)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score
Get the complete analysis for NSE:VINEETLAB
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
